AdAlta (ASX:1AD) Change In Payables And Accrued Expense : A$0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is AdAlta Change In Payables And Accrued Expense?

AdAlta's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2024 was A$0.00 Mil. It means AdAlta's Accounts Payable & Accrued Expense stayed the same from Jun. 2024 to Dec. 2024 .

AdAlta's Change In Payables And Accrued Expense for the fiscal year that ended in Jun. 2024 was A$0.00 Mil. It means AdAlta's Accounts Payable & Accrued Expense stayed the same from Jun. 2023 to Jun. 2024 .

AdAlta Change In Payables And Accrued Expense Historical Data

The historical data trend for AdAlta's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AdAlta Change In Payables And Accrued Expense Chart

AdAlta Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

AdAlta Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial												-	-	-	-	-

AdAlta Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

AdAlta Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of AdAlta's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

AdAlta Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AdAlta Ltd (ASX:1AD) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Science Drive, La Trobe Institute for Molecular Science, Room 204, LIMS2, La Trobe University, Bundoora, VIC, AUS, 3086

Website

https://www.adalta.com.au

AdAlta Ltd is engaged in drug discovery and developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The principal business of AdAlta is the discovery and development of next-generation protein and cell-based therapeutics. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases, for which current therapies are sub-optimal. Its pipeline includes Fibrosis and CAR-T cancer therapeutics.

AdAlta Headlines

No Headlines